(VIANEWS) – Equus Total Return (EQS), Eagle Point Credit Company (ECC), NCS Multistage Holdings (NCSM) are the highest sales growth and return on equity stocks on this list.
Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
1. Equus Total Return (EQS)
139.2% sales growth and 31.01% return on equity
Equus Total Return, Inc. is a business development company (BDC) specializing in leveraged buyouts, management buyouts, corporate partnerships/joint ventures, growth and expansion capital, acquisition financing, roll-up acquisition strategies, operational turnarounds, recapitalizations of existing businesses, special situations, equity and equity-oriented securities issued by privately owned companies, debt securities including subordinate debt, debt convertible into common or preferred stock, or debt combined with warrants and common and preferred stock, and preferred equity financing. It invests in small to mid-sized companies and acts as a lead investor. It invests in technology, telecommunication, financial services, natural resource and industrial manufacturing and services. It invests in companies engaged in the alternative energy, real estate, healthcare, education, e-learning, leisure and entertainment, and foreign investment sector in the United States, China, India, and Europe. It investments include common and preferred stock, debt convertible into common or preferred stock, debt combined with warrants and options, and other rights to acquire common or preferred stock. It seeks to invest in companies between $1 million to $25 million with revenues between $5 million and $150 million with EBITDA between $2 million to $50 million. It seeks to take control and non-control equity positions. Equus Total Return, Inc. was founded in 1991 and is based in Houston, Texas with additional office in Vancouver, Canada.
Earnings Per Share
As for profitability, Equus Total Return has a trailing twelve months EPS of $0.96.
PE Ratio
Equus Total Return has a trailing twelve months price to earnings ratio of 1.57. Meaning, the purchaser of the share is investing $1.57 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 31.01%.
Moving Average
Equus Total Return’s value is above its 50-day moving average of $1.47 and higher than its 200-day moving average of $1.48.
Yearly Top and Bottom Value
Equus Total Return’s stock is valued at $1.50 at 20:22 EST, way under its 52-week high of $1.95 and way higher than its 52-week low of $1.32.
2. Eagle Point Credit Company (ECC)
28.9% sales growth and 18.54% return on equity
Eagle Point Credit Company Inc. is a closed ended fund launched and managed by Eagle Point Credit Management LLC. It invests in fixed income markets of the United States. The fund invests equity and junior debt tranches of collateralized loan obligations consisting primarily of below investment grade U.S. senior secured loans. Eagle Point Credit Company Inc. was formed on March 24, 2014 and is domiciled in the United States.
Earnings Per Share
As for profitability, Eagle Point Credit Company has a trailing twelve months EPS of $1.74.
PE Ratio
Eagle Point Credit Company has a trailing twelve months price to earnings ratio of 5.86. Meaning, the purchaser of the share is investing $5.86 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 18.54%.
Sales Growth
Eagle Point Credit Company’s sales growth for the next quarter is 28.9%.
Yearly Top and Bottom Value
Eagle Point Credit Company’s stock is valued at $10.19 at 20:22 EST, under its 52-week high of $10.95 and way higher than its 52-week low of $8.60.
3. NCS Multistage Holdings (NCSM)
20.2% sales growth and 14% return on equity
NCS Multistage Holdings, Inc. provides engineered products and support services for oil and natural gas well completions and construction, and field development strategies in the United States, Canada, and internationally. It offers fracturing systems, which include casing-installed sliding sleeves, downhole frac isolation assemblies, and sand jet perforating products; enhanced recovery products, such as sliding sleeve, as well as Terrus system, an injection control device; repeat precision products comprising composite frac plugs and bridge plugs, single-use disposable setting tools, express systems, and related products; chemical and radioactive tracer diagnostics services; and well construction products, including AirLock casing buoyancy system, Vecturon and Vectraset liner hanger systems, and Toe initiation sleeves. It offers its products and services primarily to exploration and production companies for use in onshore wells through technically-trained sales force, and operating partners or sales representatives. The company was formerly known as Pioneer Super Holdings, Inc. and changed its name to NCS Multistage Holdings, Inc. in December 2016. NCS Multistage Holdings, Inc. was founded in 2006 and is headquartered in Houston, Texas.
Earnings Per Share
As for profitability, NCS Multistage Holdings has a trailing twelve months EPS of $5.65.
PE Ratio
NCS Multistage Holdings has a trailing twelve months price to earnings ratio of 3.1. Meaning, the purchaser of the share is investing $3.1 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 14%.
Moving Average
NCS Multistage Holdings’s value is above its 50-day moving average of $16.67 and way higher than its 200-day moving average of $15.82.
Volume
Today’s last reported volume for NCS Multistage Holdings is 3898 which is 29.76% above its average volume of 3004.
Revenue Growth
Year-on-year quarterly revenue growth grew by 0.7%, now sitting on 142.78M for the twelve trailing months.
Yearly Top and Bottom Value
NCS Multistage Holdings’s stock is valued at $17.50 at 20:22 EST, way under its 52-week high of $21.85 and way above its 52-week low of $12.02.
4. Merck (MRK)
14.5% sales growth and 5.31% return on equity
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes under the Keytruda, Bridion, Adempas, Lagevrio, Belsomra, Simponi, and Januvia brands, as well as vaccine products consisting of preventive pediatric, adolescent, and adult vaccines under the Gardasil/Gardasil 9, ProQuad, M-M-R II, Varivax, RotaTeq, Live Oral, Vaxneuvance, Pneumovax 23, and Vaqta names. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. The company serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians, wholesalers, government entities, veterinarians, distributors, animal producers, farmers, and pet owners. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates, which include patritumab deruxtecan, ifinatamab deruxtecan, and raludotatug deruxtecan for the treatment of multiple solid tumors both as monotherapy and/or in combination with other treatments; and AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types, and Koselugo for multiple indications. The company also has a collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. was founded in 1891 and is headquartered in Rahway, New Jersey.
Earnings Per Share
As for profitability, Merck has a trailing twelve months EPS of $0.14.
PE Ratio
Merck has a trailing twelve months price to earnings ratio of 898.14. Meaning, the purchaser of the share is investing $898.14 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 5.31%.
Previous days news about Merck(MRK)
- According to Zacks on Tuesday, 28 May, "Moderna has multiple candidates in late-stage studies - mRNA-1647 [cytomegalovirus (CMV) vaccine], mRNA-1010 (influenza vaccine), Merck (MRK Quick QuoteMRK – Free Report) -partnered mRNA-4157/V940 [individualized neoantigen therapy (INT) targeting oncology indications] and mRNA-1083 (COVID-19 plus influenza combination vaccine).", "Moderna and Merck are evaluating mRNA-4157 in two pivotal late-stage studies for melanoma and non-small cell lung cancer (NSCLC) indications. "
- What makes Merck kgaa (mkgaf) a good fit for 'trend investing'. According to Zacks on Wednesday, 29 May, "There are several stocks that passed through the screen and Merck KGaA (MKGAF Quick QuoteMKGAF – Free Report) is one of them. "
5. Erie Indemnity Company (ERIE)
11.9% sales growth and 30.15% return on equity
Erie Indemnity Company operates as a managing attorney-in-fact for the subscribers at the Erie Insurance Exchange in the United States. The company provides sales, underwriting, policy issuance, and renewal services for the policyholders on behalf of the Erie Insurance Exchange. It also offers sales related services, including agent compensation, and sales and advertising support services; and underwriting services comprise underwriting and policy processing; and other services consist of customer services and administrative support services, as well as information technology services. Erie Indemnity Company was incorporated in 1925 and is based in Erie, Pennsylvania.
Earnings Per Share
As for profitability, Erie Indemnity Company has a trailing twelve months EPS of $9.28.
PE Ratio
Erie Indemnity Company has a trailing twelve months price to earnings ratio of 42.55. Meaning, the purchaser of the share is investing $42.55 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 30.15%.
Sales Growth
Erie Indemnity Company’s sales growth is 11.2% for the current quarter and 11.9% for the next.
Dividend Yield
As stated by Morningstar, Inc., the next dividend payment is on Jul 9, 2024, the estimated forward annual dividend rate is 5.1 and the estimated forward annual dividend yield is 1.29%.
Yearly Top and Bottom Value
Erie Indemnity Company’s stock is valued at $394.87 at 20:22 EST, under its 52-week high of $420.34 and way higher than its 52-week low of $199.49.
6. Canadian Solar (CSIQ)
10.3% sales growth and 12.1% return on equity
Canadian Solar Inc., together with its subsidiaries, designs, develops, manufactures, and sells solar ingots, wafers, cells, modules, and other solar power products. The company operates through two segments, Module and System Solutions (MSS), and Energy. The MSS segment engages in the design, development, manufacture, and sale of a range of solar power products, including standard solar modules, specialty solar products, and solar system kits that are a ready-to-install packages comprising inverters, racking systems, and other accessories. It also provides engineering, procurement, and construction; and operation and maintenance (O&M) services. This segment's energy solution products include solar inverters and energy storage systems for utility, commercial, residential, and specialty product applications. Its O&M services include inspections, repair, and replacement of plant equipment; and site management and administrative support services for solar power projects. The Energy segment engages in the development and sale of solar power projects; and operation of solar power plants and sale of electricity. As of January 31, 2020, this segment had a fleet of solar power plants in operation with an aggregate capacity of approximately 880.2 MWp. The company's primary customers include distributors, system integrators, project developers, and installers/EPC companies. Canadian Solar Inc. sells its products primarily under its Canadian Solar brand name; and on an OEM basis. It has operations in North America, South America, Europe, South Africa, the Middle East, Australia, Asia, and internationally. The company was founded in 2001 and is headquartered in Guelph, Canada.
Earnings Per Share
As for profitability, Canadian Solar has a trailing twelve months EPS of $3.87.
PE Ratio
Canadian Solar has a trailing twelve months price to earnings ratio of 4.32. Meaning, the purchaser of the share is investing $4.32 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 12.1%.
Volume
Today’s last reported volume for Canadian Solar is 1919260 which is 16.35% above its average volume of 1649450.
Revenue Growth
Year-on-year quarterly revenue growth declined by 13.7%, now sitting on 7.61B for the twelve trailing months.
Sales Growth
Canadian Solar’s sales growth is negative 27.4% for the present quarter and 10.3% for the next.
Previous days news about Canadian Solar(CSIQ)
- According to Zacks on Wednesday, 29 May, "Other prominent solar players like Canadian Solar (CSIQ Quick QuoteCSIQ – Free Report) , Emeren Group (SOL Quick QuoteSOL – Free Report) and SunPower Corp. (SPWR Quick QuoteSPWR – Free Report) are expanding their footprint to reap the benefits of the expanding Battery Storage Market."
7. Alaska Air Group (ALK)
5.9% sales growth and 6.39% return on equity
Alaska Air Group, Inc., through its subsidiaries, provides passenger and cargo air transportation services. The company operates through three segments: Mainline, Regional, and Horizon. It has a network of approximately 1,300 daily flights to 115 destinations across the United States, Mexico, Canada, and Costa Rica. The company was founded in 1932 and is based in Seattle, Washington.
Earnings Per Share
As for profitability, Alaska Air Group has a trailing twelve months EPS of $1.89.
PE Ratio
Alaska Air Group has a trailing twelve months price to earnings ratio of 22.59. Meaning, the purchaser of the share is investing $22.59 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 6.39%.
Revenue Growth
Year-on-year quarterly revenue growth grew by 1.6%, now sitting on 10.46B for the twelve trailing months.
Volume
Today’s last reported volume for Alaska Air Group is 1018360 which is 51.69% below its average volume of 2108160.
8. Ituran Location and Control Ltd. (ITRN)
5.2% sales growth and 30.23% return on equity
Ituran Location and Control Ltd., together with its subsidiaries, provides location-based telematics services and machine-to-machine telematics products. It operates through two segments, Telematics Services and Telematics Products. The Telematics services segment offers stolen vehicle recovery and tracking services, which enables to locate, track, and recover stolen vehicles for its subscribers; fleet management services that enable corporate and individual customers to track and manage their vehicles in real time; and locator services that allow customers to protect valuable merchandise and equipment. This segment also delivers on-demand navigation guidance, information, and assistance, including the provision of traffic reports and directions, as well as information on the location of gas stations, car repair shops, post offices, hospitals, and other facilities; and Connected Car, a service platform that includes a back-office application, a telematics device installed in the vehicle, mobile apps for IOS and Android users, and interface using the car infotainment screen, as well as usage based insurance and auto financing. This segment serves insurance companies and agents, car manufacturers, dealers and importers, cooperative sales channels, and private subscribers. The Telematics Products segment offers Base Site, a radio receiver that includes a processor and a data computation unit to collect and send data to and from transponders, and to control centers; Control Center, a center consisting of software used to collect data from various base sites, conduct location calculations, and transmit location data to various customers and law enforcement agencies; navigation and tracking devices installed in vehicles; and SMART, a portable transmitter installed in vehicles that sends a signal to the base site enabling the location of vehicles, equipment, or an individual. Ituran Location and Control Ltd. was incorporated in 1994 and is headquartered in Azor, Israel.
Earnings Per Share
As for profitability, Ituran Location and Control Ltd. has a trailing twelve months EPS of $2.41.
PE Ratio
Ituran Location and Control Ltd. has a trailing twelve months price to earnings ratio of 11.41. Meaning, the purchaser of the share is investing $11.41 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 30.23%.
Dividend Yield
As claimed by Morningstar, Inc., the next dividend payment is on Mar 19, 2024, the estimated forward annual dividend rate is 0.93 and the estimated forward annual dividend yield is 3.36%.
